Feeds:
Posts
Comments

Posts Tagged ‘HIVMA’

The International AIDS Society (IAS) announced Monday that the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA), with its Center for Global Health Policy, will be one of two local scientific partners for the 2012 International AIDS Conference — to be held in Washington, DC in July 2012. HIVMA represents more than 3800 physicians, scientists and other health professionals who work in the field of HIV medicine in all 50 states and in a wide range of countries across the globe.

The National Institutes of Health has been selected to be the other local scientific partner. Other community local partners include the Black AIDS Institute, the District of Columbia Department of Health, the Office of National AIDS Policy, The US Positive Women’s Network. Sidaction was selected as the civil society partner.

In a press release, Chair of AIDS 2012 and IAS President-Elect Elly Katabira said, “With the announcement of these impressive and diverse civil society and local partnerships for AIDS 2012, we can look forward to ensuring that the conference further strengthens the U.S. role in global AIDS initiatives and re-energizes both the global and U.S domestic response to the epidemic.”

The IAS is the world’s leading independent association of HIV professionals, with 14,000 members in 190 countries. Along with its permanent partners, the Global Network of People Living with HIV, the International Council of AIDS Service Organizations, the International Community of Women with HIV/AIDS, and the United Nations Joint Program on HIV/AIDS, they will host the 2010 International AIDS Conference in Vienna, Austria, from July 18-23. Stay tuned to ScienceSpeaks for special articles leading up to the Conference and for live blogging from Vienna next week.

In other news, HIVMA chair Michael Saag, MD, will attend the unveiling of the National HIV/AIDS Strategy at the White House Tuesday afternoon. He will also attend an evening reception for the AIDS community where President Obama is expected to speak. The Global Health Center’s Director Christine Lubinski and HIVMA Executive Director Andrea Weddle also will be there.

Advertisements

Read Full Post »

The latest HIV clinical care information is now available in a compendium of the year’s HIV-related articles from Clinical Infectious Diseases and The Journal of Infectious Diseases.

The publication, 2009 Clinical Issues in HIV Medicine: Recent Advances & Challenges, was edited by Kenneth Mayer, MD, Miriam Hospital, Brown University and Daniel Kuritzkes, MD, Brigham and Women’s Hospital, Harvard Medical School. It includes a wide range of HIV-related articles, including a piece on when to start HIV therapy, race and sex differences in ART use and mortality among HIV-positive persons, and the NIAID’s research agenda on drug-resistant TB.

Click here to see this important publication put out by the HIV Medicine Association.

Read Full Post »

The Center for Global Health Policy & the HIV Medicine Association teamed up last week for a series of advocacy meetings on Capitol Hill, drawing attention to the domestic and global fight against HIV/AIDS.

The meetings—featuring top HIV/AIDS doctors and researchers—come at a critical moment, with Congress set to make vital funding decisions about HIV/AIDS programs in the coming weeks.

In one session, Drs. Kenneth Mayer, of Brown University; Carol Dukes Hamilton, of Family Health International; and Daniel Kuritzkes, of Brigham & Women’s Hospital, talked with Shannon Smith, a top aide to the Senate Foreign Relations Committee and the lead Senate staffer in last year’s reauthorization of PEPFAR (all pictured below). The doctors stressed the importance of not slowing down the response to the global AIDS epidemic, despite the tough economic climate. 

Drs. Kuritzkes, Mayer, and Hamilton talk about global AIDS funding with Senate aide Shannon Smith

Drs. Kuritzkes, Mayer, and Hamilton talk about global AIDS funding with Senate aide Shannon Smith

 

 

 

 

 

 

 

 

 

 

 

 

In a second session, Dr. Sharon Nachman met with Jordan Baugh, a legislative assistant to Sen. Kirsten Gillibrand, D-N.Y. Dr. Nachman made a very strong case for robust funding for bilateral TB programs, and Baugh seemed engaged and interested in her argument.

Dr. Nachman speaks with aide to Sen. Gillibrand about the need for robust TB funding

Dr. Nachman speaks with aide to Sen. Gillibrand about the need for robust TB funding

In all, the Global Center and HIVMA participated in more than two dozen such sessions with key House and Senate staffers. The meetings were done in coordination with the HIVMA board meeting, held in Washington on Friday, June 5. 

The Global Center and HIVMA staff will be following the funding decisions in Congress closely; check back for updates on this and other key legislative action on HIV/AIDS & TB-related issues.

Read Full Post »

Well, we may not like President Obama’s budget too much. And we’re more than a little worried about his global health proposal. But at least Obama is putting good policy folks in place to combat infectious diseases, here and abroad.

Today, the president picked Dr. Thomas Frieden as director of the Centers for Disease Control and Prevention, a fantastic move and one that bodes well for HIV and TB prevention and treatment. Here’s the press release the Center for Global Health Policy, along with IDSA and HIVMA, put out today after the news became official:

 Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet. Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet. Right-click here to download pictures. To help protect your privacy, Outlook prevented automatic download of this picture from the Internet.

Deirdre Shesgreen
Senior Communications Officer
Center for Global Health Policy
703-740-4954
dshesgreen@idsociety.org

Physicians and Scientists Hail Choice of Thomas Frieden to Head the CDC

May 15, 2009

The Infectious Diseases Society of America (IDSA), HIV Medicine Association (HIVMA), and the IDSA/HIVMA Center for Global Health Policy applaud President Barack Obama for his appointment of Thomas Frieden, MD, as director of the Centers for Disease Control and Prevention. (CDC)

Dr. Frieden’s experience—as an epidemiologist, an administrator, a researcher and a clinician—make him an outstanding choice to lead the CDC at this critical moment in protecting America’s public health. Dr. Frieden will bring to the CDC unwavering dedication, immense talents, and a strong track record of battling deadly epidemics, such as tuberculosis, HIV/AIDS, and most recently the 2009 Influenza A: H1N1 virus that threatens to spark the next influenza pandemic.
 
“Thomas Frieden demonstrated extraordinary vision, leadership and organizational ability in containing the multidrug resistant TB epidemic in New York in the early 1990s,” said Richard Chaisson, MD, a member of the Global Center’s advisory committee and director of the Johns Hopkins Center for Tuberculosis Research. “He then took that expertise to India, where he transformed that nation’s TB program, creating a model for the world and saving hundreds of thousands of lives as a consequence.  His commitment to using scientific approaches to disease control will serve the nation well.  He is an outstanding choice to lead the CDC.”
 
Roy Gulick, MD, chief of the infectious diseases division at Weill Medical College of Cornell University and a member of HIVMA, said Dr. Frieden will be a forceful advocate for putting evidenced-based science into practice in the battle against HIV/AIDS. 
 
“As health commissioner of New York City, Tom Frieden increased community services for the infected community.  He emphasized prevention by promoting needle exchange and condom use.  He worked hard to promote routine HIV testing so that more New Yorkers would know their status.  He worked closely with HIV providers to monitor the HIV epidemic in New York and reached out to communities of color,” Dr. Gulick said. “With his training in infectious diseases and public health and his track record as New York City health commissioner, he is an outstanding choice for director of the CDC—he certainly will make a difference for those infected and affected by HIV in the U.S.”
 
“As an infectious disease physician and a New Yorker, I have been incredibly impressed with Dr. Freiden’s response to the recent Influenza A H1N1 outbreak and previous outbreaks of other diseases. Given the potential for an influenza pandemic, all of us should take comfort in having him at the helm at CDC,” said Anne Gershon, MD, president of IDSA and a pediatric infectious disease specialist at Columbia University College of Physicians in New York. “He will be a standout at CDC, but we will miss him in New York.”
 

Read Full Post »